ArticleNeurologia medico-chirurgica2025
Outcome after Endovascular Treatment of Patients with Ruptured Cerebral Aneurysm over 90 Years of Age.
Article in Neurologia medico-chirurgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impact of Aneurysm Size and Flow Diverter Use on Outcomes After Endovascular Therapy of Unruptured Paraclinoid Aneurysms.Stroke (Hoboken, N.J.) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For ruptured cerebral aneurysms over 90 years of age, the outcome and the safety after endovascular treatment are not well-known. This multicenter retrospective registry enrolled patients with ruptured cerebral aneurysms after endovascular treatment from January 2015 to December 2019 in Japan. We investigated differences between the patients over 90 years (age ≥ 90) and those under 90 years of age (age <90). The primary outcome was defined as a modified Rankin scale 0-2 at 30 days. Secondary outcomes were all-cause death and returned to premorbid modified Rankin scale at 30 days. Safety outcomes were the incidence of ischemic stroke and technical complications. Among 8,024 patients with aneurysm, 204 were aged ≥ 90 years and 7,820 were <90 years, those of median age were 92 and 65 years. The proportion of females and premorbid modified Rankin scale was higher in the age ≥ 90 group (n [%]; 191 [93.6] vs. 5,395 [69.0], median [interquartile range]; 1 [0-2] vs. 0 [0-0]). The modified Rankin scale 0-2 at 30 days was lower in age ≥ 90 patients than in age <90 patients (13.2% vs. 56.2%, adjusted odds ratio [95% confidence intervals]; 0.13 [0.08-0.21]). In age ≥ 90 patients, all-cause death was significantly higher (adjusted odds ratio [95% confidence intervals]; 1.85 [1.19-2.86]) and returned to premorbid modified Rankin scale was significantly lower (adjusted odds ratio [95% confidence intervals]; 0.26 [0.17-0.39]). However, safety outcomes were not significantly different between both groups. In this population undergoing endovascular treatment for ruptured cerebral aneurysms, patients older than 90 years had a poor prognosis but no difference in having perioperative complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.